Literature DB >> 28003216

Challenges in Interpretation of Diagnostic Test Results in a Mumps Outbreak in a Highly Vaccinated Population.

L A Trotz-Williams1, N J Mercer2, K Paphitis2, J M Walters2, D Wallace2, E Kristjanson3, J Gubbay3, T Mazzulli4.   

Abstract

In spite of a greatly reduced incidence rate due to vaccination, mumps outbreaks continue to occur in several areas of the world, sometimes in vaccinated populations. This article describes an outbreak in a highly vaccinated population in southwestern Ontario, Canada, and the challenges encountered in interpreting the results of diagnostic tests used in the outbreak. During the outbreak, patients were interviewed and classified according to the outbreak case definition, and specimens were collected for diagnostic testing according to Ontario guidelines. Twenty-seven individuals were classified as confirmed cases (n = 19) or suspect cases (n = 8) according to the case definition, only 9 of which were laboratory-confirmed cases: 7 confirmed by reverse transcriptase PCR (RT-PCR) and 2 by IgM serology. All 19 confirmed cases represented patients who were associated with secondary schools in the local area and had been vaccinated against mumps with one (n = 2) or two (n = 17) doses of the measles-mumps-rubella (MMR) vaccine. This is the first published report of an outbreak of mumps in Ontario in which all confirmed cases had been vaccinated against the disease. It highlights the limitations of and difficulties in interpreting current mumps diagnostic tests when used in vaccinated individuals.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  MMR; immunized population; mumps; mumps diagnostic tests; mumps serology; mumps vaccination

Mesh:

Substances:

Year:  2017        PMID: 28003216      PMCID: PMC5299122          DOI: 10.1128/CVI.00542-16

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  22 in total

Review 1.  Mumps resurgence in the United States.

Authors:  Vikas S Kancherla; I Celine Hanson
Journal:  J Allergy Clin Immunol       Date:  2006-08-28       Impact factor: 10.793

2.  Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage.

Authors:  Rebecca H Bitsko; Margaret M Cortese; Gustavo H Dayan; Paul A Rota; Luis Lowe; Susan C Iversen; William J Bellini
Journal:  J Clin Microbiol       Date:  2008-01-09       Impact factor: 5.948

3.  Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity.

Authors:  Margaret M Cortese; Albert E Barskey; Gary E Tegtmeier; Cheryl Zhang; Laurie Ngo; Moe H Kyaw; Andrew L Baughman; Jay E Menitove; Carole J Hickman; William J Bellini; Gustavo H Dayan; Gail R Hansen; Steven Rubin
Journal:  J Infect Dis       Date:  2011-09-20       Impact factor: 5.226

4.  Mumps outbreak and laboratory diagnosis.

Authors:  Mylène Maillet; Eric Bouvat; Nicole Robert; Monique Baccard-Longère; Christine Morel-Baccard; Patrice Morand; Astrid Vabret; Jean-Paul Stahl
Journal:  J Clin Virol       Date:  2014-11-15       Impact factor: 3.168

5.  Rapid and sensitive detection of mumps virus RNA directly from clinical samples by real-time PCR.

Authors:  Kazue Uchida; Michiyo Shinohara; Shin-ichi Shimada; Yukari Segawa; Rie Doi; Atushi Gotoh; Ryo Hondo
Journal:  J Med Virol       Date:  2005-03       Impact factor: 2.327

6.  Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009.

Authors:  Jennifer S Rota; Jennifer B Rosen; Margaret K Doll; Rebecca J McNall; Marcia McGrew; Nobia Williams; Elena N Lopareva; Albert E Barskey; Amado Punsalang; Paul A Rota; William R Oleszko; Carole J Hickman; Christopher M Zimmerman; William J Bellini
Journal:  Clin Vaccine Immunol       Date:  2013-01-16

7.  Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain.

Authors:  Irene Barrabeig; Josep Costa; Ariadna Rovira; M Angeles Marcos; Ricard Isanta; Rubén López-Adalid; Ana Cervilla; Nuria Torner; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

8.  Outbreak of mumps in a vaccinated child population: a question of vaccine failure?

Authors:  Corinne Vandermeulen; Mathieu Roelants; Marijke Vermoere; Katelijn Roseeuw; Patrick Goubau; Karel Hoppenbrouwers
Journal:  Vaccine       Date:  2004-07-29       Impact factor: 3.641

9.  Mumps vaccine performance among university students during a mumps outbreak.

Authors:  Margaret M Cortese; Hannah T Jordan; Aaron T Curns; Patricia A Quinlan; Kim A Ens; Patricia M Denning; Gustavo H Dayan
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

10.  Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?

Authors:  J Eriksen; I Davidkin; G Kafatos; N Andrews; C Barbara; D Cohen; A Duks; A Griskevicius; K Johansen; K Bartha; B Kriz; G Mitis; J Mossong; A Nardone; D O'Flanagan; F DE Ory; A Pistol; H Theeten; K Prosenc; M Slacikova; R Pebody
Journal:  Epidemiol Infect       Date:  2012-06-12       Impact factor: 4.434

View more
  6 in total

Review 1.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

2.  Diagnostic Yield of Laboratory Methods and Value of Viral Genotyping during an Outbreak of Mumps in a Partially Vaccinated Population in British Columbia, Canada.

Authors:  Alexandra Nunn; Shazia Masud; Mel Krajden; Monika Naus; Agatha N Jassem
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

3.  Evaluating the use of whole genome sequencing for the investigation of a large mumps outbreak in Ontario, Canada.

Authors:  P J Stapleton; A Eshaghi; C Y Seo; S Wilson; T Harris; S L Deeks; S Bolotin; L W Goneau; J B Gubbay; S N Patel
Journal:  Sci Rep       Date:  2019-08-30       Impact factor: 4.379

Review 4.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

5.  Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using Cox-Proportional Hazard Model.

Authors:  Zhiying Yin; Canjie Zheng; Quanjun Fang; Xiaoying Gong; Guoping Cao; Junji Li; Ziling Xiang; Wei Song
Journal:  J Immunol Res       Date:  2021-11-05       Impact factor: 4.818

6.  Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, Canada.

Authors:  Wallis Rudnick; Sarah Wilson; Jo Ann Majerovich; Michelle Haavaldsrud; Marene Gatali; Cai-Lei Matsumoto; Shelley Deeks
Journal:  Hum Vaccin Immunother       Date:  2021-07-22       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.